Groeifonds 2021

Aging, type 2 diabetes, shortage of healthcare personnel; our society is facing major challenges that require more knowledge and groundbreaking innovations. This offers opportunities for scientists, companies and public parties. NWO is responding to this by investing more than €100 million annually through various subsidy instruments in research in which public and private parties work together.

The role of SME’s

In order to achieve social and economic impact, the participation of SMEs is necessary and is therefore an important partner in research in all instruments. By sharing knowledge and collaborating on innovations, research results can be translated into solutions for society. For research that is financed within the Knowledge and Innovation Covenant (KIC), NWO applies incentives to involve SME’s more. NWO has opened 2 new instruments. om het MKB beter te betrekken.

About the instruments from NWO

  1. In ‘Question for Partners’, a public and/or private partner develops a research program in partnership with NWO around a specific knowledge and/or development question. The partner is a co-funder (min. €1.5 million in cash) in the program and NWO will double this amount. This instrument is therefore particularly suitable for (a combination of) public and/or private parties that want to initiate a thematic research program of a considerable size.
  2. In ‘Question for Consortia’ a consortium of knowledge institutes, public and private parties contribute to a research proprosal to find answer to a self-chosen knowledge or development question.

The financial NWO contribution to these instruments is available for fundamental and practice-oriented research, carried out by scientists in collaboration with companies. The degree of co-financing by private parties for these instruments is set at 50%, and at least 30% of the total size of the partnership.

More information about these and other research programmes can be found here www.nwo.nl/kic.

Source: HollandBio news

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.